Smith & Nephew plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on January 23, 2026, serves as a notification and public disclosure of transactions by Persons Discharging Managerial Responsibilities (PDMRs) and persons closely associated with them. The filing is made in accordance with the UK Market Abuse Regulation. The reporting period covers transactions executed on January 16, 2026.
Key Financial Metrics
The filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. It exclusively details share purchase transactions.
Material Changes and Transaction Details
The document reports the purchase of American Depositary Shares (ADS) by senior executives as participants in the Company's Employee Stock Purchase Plan. All transactions occurred on the New York Stock Exchange at a uniform price of $25.90 per share.
- Deepak Nath (Chief Executive Officer): Purchased 410,104.98 ADS.
- Paul Connolly (President, Global Operations): Purchased 410,104.98 ADS.
- Scott Schaffner (President, Sports Medicine): Purchased 242.58803 ADS.
- Craig Gaffin (President, Global Orthopaedics): Purchased 206.79536 ADS.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risk factors, contingencies, or unusual items. The scope is limited to regulatory disclosure of insider trading activity.
Key Facts for Investor Verification
- Verify the total volume of shares purchased by the CEO and President of Global Operations, which were identical in this transaction.
- Confirm the transaction price of $25.90 against the market price on January 16, 2026.
- Note that these purchases were made under the Employee Stock Purchase Plan, not as open-market discretionary trades.
- Check subsequent filings for any changes in the company's financial performance, as this document contains no operational data.